A recent study proposed that the anthocyanin extract from blueberries ameliorates depression-like behavior in CUMS by upregulating monoamine neurotransmitter levels and BDNF expression and inhibiting MAOA, which promotes neurogenesis via the ERK/CREB/BDNF signaling pathways [143]. Here, CREB1 is linked to depressive disorder.